Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001012870-02-004739
Filing Date
2002-12-23
Accepted
2002-12-23 14:03:16
Documents
6
Period of Report
2002-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1035199
3 LIST OF SUBSIDIARIES dex211.htm EX-21.1 2371
4 CONSENT OF PRICEWATERHOUSECOOPERS LLP dex231.htm EX-23.1 1274
5 CONSENT OF PRICEWATERHOUSECOOPERS LLP dex232.htm EX-23.2 1251
6 CERTIFICATION BY CHIEF EXECUTIVE OFFICER dex991.htm EX-99.1 3165
7 CERTIFICATION BY CHIEF FINANCIAL OFFICER dex992.htm EX-99.2 3410
  Complete submission text file 0001012870-02-004739.txt   1048958
Mailing Address PO BOX 14287 RESEARCH TRIANGLE PK NC 27709
Business Address 79 T.W. ALEXANDER DRIVE 4401 RESEARCH COMMONS- SUITE 200 RESEARCH TRIANGLE PK NC 27709 9195588688
INCARA PHARMACEUTICALS CORP (Filer) CIK: 0000936538 (see all company filings)

EIN.: 561924222 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 000-27410 | Film No.: 02866590
SIC: 2834 Pharmaceutical Preparations